Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 173 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Southern Cancer Center Pc — Daphne, Alabama (13.7 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Depemokimab in Participants of 6 to 11 Years of Age
Asthma
Phase 3
Interventional 34 participants sought
GSK Investigational Site — Mobile, Alabama (4.5 mi)
· Sponsor: GlaxoSmithKline
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fairhope, AL Investigative Site 10004 — Fairhope, Alabama (16.6 mi)
· Sponsor: Colorado Prevention Center
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Mobile, Alabama (4.5 mi)
· Sponsor: TG Therapeutics, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Hernia, Ventral, Hernia, Inguinal
N/A
Interventional 160 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Tela Bio Inc
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 160 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
USA Health Children's and Women's Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Tricuspid Valve Disease
N/A
Interventional 78 participants sought
Springhill Memorial Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Corvivo Cardiovascular, Inc.
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
AMR Clinical — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Mobile Cardiology Associates — Mobile, Alabama (4.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Mobile, Alabama (4.5 mi)
· Sponsor: AstraZeneca
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Mobile Heart Specialists PC — Mobile, Alabama (4.5 mi)
· Sponsor: Amgen
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2, Phase 3
Interventional 1,156 participants sought
Pulmonary Associates of Mobile, P.C. — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
The University of South Alabama, Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Genelux Corporation
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
Parkinson Disease, Depressive Symptoms
N/A
Interventional 40 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: University of South Alabama
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Lipoprotein(a)
Phase 2
Interventional 750 participants sought
AMR Clinical Mobile ( Site 0149) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: PedAL BCU, LLC
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Cardiovascular Disorder, Classic Hodgkin Lymphoma
N/A
Observational 190 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Diagnostic and Medical Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Boehringer Ingelheim
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH